Health Company Announces Major Partnership To Develop Novel Drug

NLS Pharmaceutics Announces Selection of Strategic Partner and Secures Bridge Loan: A Significant Step towards Achieving their Goals.

NLS Pharmaceutics Ltd., a Swiss biopharmaceutical company focused on the development of novel treatments for neurobehavioral disorders, has recently made two significant announcements that could greatly impact its future. The company announced the selection of a strategic partner and the securing of a bridge loan, both of which are critical milestones i…